Total Payments
$1,544
2023 Payments
$119.58
Companies
13
Transactions
48
Medicare Patients
2,672
Medicare Billing
$288,761
Payment Breakdown by Category
Food & Beverage$1,544 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,544 | 48 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $444.71 | 27 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $359.35 | 5 | $0 (2022) |
| Theravance Biopharma Inc. | $122.65 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $117.92 | 1 | $0 (2019) |
| Philips Electronics North America Corporation | $92.40 | 1 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $80.60 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $73.26 | 5 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $50.62 | 1 | $0 (2018) |
| Insmed, Inc. | $47.97 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $47.62 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $119.58 | 5 | PFIZER INC. ($76.65) |
| 2022 | $191.80 | 5 | Philips Electronics North America Corporation ($92.40) |
| 2021 | $92.25 | 5 | PFIZER INC. ($92.25) |
| 2020 | $60.73 | 4 | PFIZER INC. ($60.73) |
| 2019 | $476.30 | 9 | AstraZeneca Pharmaceuticals LP ($172.17) |
| 2018 | $320.14 | 10 | AstraZeneca Pharmaceuticals LP ($140.61) |
| 2017 | $283.53 | 10 | Theravance Biopharma Inc. ($122.65) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/11/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: Rare Disease | ||||||
| 07/18/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/11/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/02/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/09/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Rare Disease | ||||||
| 10/11/2022 | Philips Electronics North America Corporation | (8744) Trilogy Evo (Device) | Food and Beverage | Cash or cash equivalent | $92.40 | General |
| Category: Medical Device | ||||||
| 09/28/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $46.57 | General |
| 09/16/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/27/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/12/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/10/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/17/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/12/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/26/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/28/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/18/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/08/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/15/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/24/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/12/2019 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $47.97 | General |
| 12/02/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $117.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/27/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $16.69 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 10/01/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $67.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/28/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/09/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $104.28 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 709 | 1,142 | $271,595 | $75,357 |
| 2022 | 7 | 596 | 943 | $219,283 | $61,354 |
| 2021 | 7 | 657 | 1,022 | $251,465 | $72,480 |
| 2020 | 9 | 710 | 1,138 | $267,789 | $79,570 |
Total Patients
2,672
Total Services
4,245
Medicare Billing
$288,761
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 253 | 644 | $135,734 | $37,408 | 27.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 99 | 99 | $45,913 | $12,463 | 27.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 180 | 184 | $39,744 | $10,820 | 27.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 64 | 102 | $32,334 | $8,979 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 24 | $5,472 | $2,256 | 41.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $5,768 | $1,449 | 25.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 17 | 17 | $5,202 | $1,443 | 27.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 21 | 21 | $189.00 | $176.40 | 93.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 11 | 11 | $528.00 | $144.32 | 27.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 13 | 13 | $403.00 | $134.55 | 33.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 11 | 11 | $308.00 | $83.71 | 27.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 215 | 467 | $86,862 | $24,274 | 27.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 99 | 190 | $50,730 | $14,446 | 28.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 154 | 158 | $29,546 | $8,321 | 28.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 43 | 43 | $22,231 | $6,321 | 28.4% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 39 | 39 | $18,291 | $4,930 | 27.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 32 | 32 | $5,984 | $1,657 | 27.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $5,639 | $1,406 | 24.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 217 | 446 | $82,696 | $24,249 | 29.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 130 | 265 | $70,621 | $20,596 | 29.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 72 | 72 | $37,176 | $10,603 | 28.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 154 | 155 | $28,932 | $8,404 | 29.0% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 42 | 42 | $19,715 | $5,428 | 27.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 20 | 20 | $8,229 | $2,053 | 24.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 22 | 22 | $4,096 | $1,146 | 28.0% |
About Dr. David Jerden, MD
Dr. David Jerden, MD is a Internal Medicine healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255376513.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Jerden, MD has received a total of $1,544 in payments from pharmaceutical and medical device companies, with $119.58 received in 2023. These payments were reported across 48 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,544).
As a Medicare-enrolled provider, Jerden has provided services to 2,672 Medicare beneficiaries, totaling 4,245 services with total Medicare billing of $288,761. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Knoxville, TN
- Active Since 06/19/2006
- Last Updated 08/20/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1255376513
Products in Payments
- ELIQUIS (Drug) $398.58
- FASENRA (Drug) $214.23
- CHANTIX (Drug) $119.39
- XARELTO (Drug) $117.92
- (8744) Trilogy Evo (Device) $92.40
- COMBIVENT RESPIMAT (Drug) $80.60
- LOKELMA (Drug) $67.89
- DIFICID (Drug) $50.62
- Prolastin-C (Biological) $47.61
- ULTOMIRIS (Biological) $42.93
- BRILINTA (Drug) $30.66
- ANDEXXA (Biological) $16.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Knoxville
Ross Nesbit, Md, MD
Internal Medicine — Payments: $432,287
Internal Medicine $432,287
Dr. Dennis Deruelle, Md, Fhm, MD, FHM
Internal Medicine — Payments: $289,726
Internal Medicine $289,726
Ayaz Rahman, M.d, M.D
Internal Medicine — Payments: $250,855
Internal Medicine $250,855
Dr. David Chism, Md, MD
Internal Medicine — Payments: $47,436
Internal Medicine $47,436
Morgan Randall
Internal Medicine — Payments: $45,633
Internal Medicine $45,633
Kimberly Morris, Md, MD
Internal Medicine — Payments: $32,540
Internal Medicine $32,540